$143 MILLION in cash and cash equivalents at 12/31/12. How much cash do you think SPPI has today? ALOT. How much will SPPI have at 12/31/13? ALOT.
Plus, $180 million in annual revenues is very meaningful and Raj is a hawk on expenses. 3 pending FDA filings and Apaziquone is a complete 110% home run ball if approved. The release of study results for Apaziquone without blood in the bladder will be very indicative of the increased likelihood of FDA approval.
Thumbs down in under 3 minutes! Joe, all posts must include Raj-bashing. Nothing else matters. Orders of Folotyn have ceased because Raj can't be trusted, so there will be no money left.
Please include these kinds of things in the future to avoid those dreaded thumbs downs.
Yes, it is just terrible that SPPI has a laughable $400 million market cap with $180 MM in annual revenues with 3 new FDA filings in the next 12 months for cancer drugs with a potential combined annual revenue run rate of more than a BILLION Dollars per year.
$143 MM in cash as of 12/31/12. Plus, a 10 to 12 drug pipeline behind it including the two SP drugs for breast cancer etc.
Is there a more undervalued BioTech today?......not even close.